Nanodiamonds
(NDs) are increasingly being assessed as potential
candidates for drug delivery in cancer cells and they hold great promise
in overcoming the side effects of traditional chemotherapeutics. In
the current work, carboxylic acid functionalized nanodiamonds (ND-COOH)
were covalently modified with poly(amidoamine) dendrimer (PAMAM) to
form amine-terminated nanodiamonds (NP). Unlike ND-COOH, the chemically
modified nanodiamond platform NP revealed a pH-independent aqueous
dispersion stability, enhancing its potential as an effective carrier.
Physical encapsulation of poorly water soluble cabazitaxel (CTX) drug
on NP formed ND-PAMAM-CTX (NPC) nanoconjugates and substantially reduced
the size of CTX from micrometer to nanometer. CTX was localized within
the pores of nanoparticle aggregates and the cavities of the PAMAM
dendrimer, thus facilitating the loaded drug’s controlled and
sustained release. NPC’s cumulative CTX release efficiency
was determined to be ∼95% at pH 4 after 96 h. A high cellular
uptake of NPC both within the cytoplasm and nucleus of U87 cells is
confirmed, accounting for a reduced IC50 value (1 nM).
Both the cell cycle and Western blot analyses confirmed enhanced cell
death and suppressed tubulin protein expression in NPC-treated cells.
A significantly high inhibition to cell division with early apoptosis
and reduced metastasis demonstrates the effective loading of CTX dosages
on the nanocarrier. The present work highlights the potential of a
newly designed nanocarrier NP as an efficient nanocargo for cellular
delivery applications and may provide future insights to treat one
of the most aggressive tumors in neuro-oncological research, glioblastoma
multiforme (GBM).